AU653366B2 - Method for inhibiting the infectivity of human immunodeficiency virus - Google Patents

Method for inhibiting the infectivity of human immunodeficiency virus

Info

Publication number
AU653366B2
AU653366B2 AU86317/91A AU8631791A AU653366B2 AU 653366 B2 AU653366 B2 AU 653366B2 AU 86317/91 A AU86317/91 A AU 86317/91A AU 8631791 A AU8631791 A AU 8631791A AU 653366 B2 AU653366 B2 AU 653366B2
Authority
AU
Australia
Prior art keywords
gpl20
antibodies
hiv
binding
lymphocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU86317/91A
Other languages
English (en)
Other versions
AU8631791A (en
Inventor
Franco Celada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital for Joint Diseases
Original Assignee
Hospital for Joint Diseases
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital for Joint Diseases filed Critical Hospital for Joint Diseases
Publication of AU8631791A publication Critical patent/AU8631791A/en
Application granted granted Critical
Publication of AU653366B2 publication Critical patent/AU653366B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU86317/91A 1990-09-28 1991-08-26 Method for inhibiting the infectivity of human immunodeficiency virus Ceased AU653366B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58972290A 1990-09-28 1990-09-28
US589722 1990-09-28
PCT/US1991/006079 WO1992005799A1 (en) 1990-09-28 1991-08-26 Method for inhibiting the infectivity of human immunodeficiency virus

Publications (2)

Publication Number Publication Date
AU8631791A AU8631791A (en) 1992-04-28
AU653366B2 true AU653366B2 (en) 1994-09-29

Family

ID=24359218

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86317/91A Ceased AU653366B2 (en) 1990-09-28 1991-08-26 Method for inhibiting the infectivity of human immunodeficiency virus

Country Status (4)

Country Link
EP (1) EP0550516A1 (enExample)
AU (1) AU653366B2 (enExample)
CA (1) CA2091253A1 (enExample)
WO (1) WO1992005799A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06509417A (ja) * 1991-07-16 1994-10-20 トランスメッド　バイオテック　インコーポレイテッド 多重検体の同時分析の方法と構成
AU6080794A (en) * 1992-12-31 1994-08-15 Ramot University Authority For Applied Research And Industrial Development Ltd. Antibodies directed against binding-associated epitopes
US5843454A (en) * 1993-05-07 1998-12-01 Akzo Nobel N.V. HIV immunogenic complexes
CA2195238A1 (en) * 1994-07-19 1996-02-01 Robin Bachelder Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding
EP0903860A1 (en) 1997-09-17 1999-03-24 Matsushita Electric Industrial Co., Ltd. PLL frequency synthesizer
WO2000039304A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP1980617A1 (en) 1998-12-31 2008-10-15 Novartis Vaccines and Diagnostics, Inc. Improved expression of HIV polypeptides and production of virus-like particles
AU2596600A (en) 1998-12-31 2000-07-31 Chiron Corporation Modified hiv env polypeptides
US7311920B1 (en) 1999-10-08 2007-12-25 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
PT1137786E (pt) * 1999-10-08 2007-07-13 Univ Maryland Biotech Inst Quimeras de proteína do invólucro/receptor de vírus e métodos de utilização.
US6908612B2 (en) 1999-10-08 2005-06-21 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
FR2799974B1 (fr) * 1999-10-25 2001-11-30 Aventis Pasteur Complexe deglycosyle proteine env/cd4 et son utilisation pour la vaccination contre le vih
CA2452015C (en) 2001-07-05 2012-07-03 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591227B1 (fr) * 1985-12-06 1988-11-10 Pasteur Institut Peptides capables d'inhiber les interactions entre les virus lav et les lymphocytes t4, produits qui en sont derives et leurs applications
ATE122237T1 (de) * 1987-05-29 1995-05-15 Tanox Biosystems Inc Hiv-1 neutralisierende monoklonale antikörper.
US4908203A (en) * 1987-09-09 1990-03-13 Johnson & Johnson Method for inducing HIV neutralizing antibodies using an internal image idiotope

Also Published As

Publication number Publication date
EP0550516A1 (en) 1993-07-14
AU8631791A (en) 1992-04-28
EP0550516A4 (enExample) 1994-04-06
CA2091253A1 (en) 1992-03-29
WO1992005799A1 (en) 1992-04-16

Similar Documents

Publication Publication Date Title
Celada et al. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding.
Chanh et al. Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus.
US6057421A (en) Variable heavy and light chain regions of murine monoclonal antibody 1F7
EP0308936B1 (en) Antibody heteroconjugates for the killing of HIV-infected cells
US6812024B2 (en) Anti-paratopic antibody as an immunogen
AU632475B2 (en) Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5854400A (en) Monoclonal antibodies which neutralize HIV-1 infection
WO1993017694A1 (en) An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease
JPH05506573A (ja) ＨＩＶ―１糖タンパクに反応性を有するＩｇＧ―１ヒトモノクローナル抗体およびその使用方法
CA2066607A1 (en) Peptides associated with the cd4 binding region of gp120 and their methods of use
AU8631791A (en) Method for inhibiting the infectivity of human immunodeficiency virus
EP0366718A1 (en) HIV-1 NEUTRALIZING MONOCLONAL ANTIBODIES.
EP0492560B1 (en) Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of HIV-1, and related peptides
US6008044A (en) Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC)
WO1992015885A1 (en) Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations
EP0503916A1 (en) Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations
EP0335134A2 (en) Mouse monoclonal antibody to human immunodeficiency virus gp41 protein
US5691135A (en) Immunoglobulin superantigen binding to gp 120 from HIV
Sölder et al. Anti-viral antibodies in HIV (HTLV-III) infection possess auto-antibody activity against a CH1 domain determinant in human IgG: possible immunological consequences
Müller et al. Generation and specificity of monoclonal anti-idiotypic antibodies against human HIV-specific antibodies. I. Cross-reacting idiotopes are expressed in subpopulations of HIV-infected individuals
US6083504A (en) Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
JP2583555B2 (ja) ヒト免疫不全ウイルス（ｈｉｖ）の検出と治療のための方法および物質
WO1989010416A1 (en) PROTECTIVE PEPTIDES DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS-1 gp160
KR920001772B1 (ko) 포유류 중의 HIV-억제 항체 유도성 사람 면역 결핍 바이러스(HIV) env-암호화된 펩타이드
AU653926B2 (en) HIV-1 ENV fragment fusion protein